Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcome measures in psoriatic arthritis.
Gladman DD, Mease PJ, Krueger G, van der Heidje DM, Antoni C, Helliwell PS, Kavanaugh AF, Nash P, Ritchlin CT, Strand CV, Taylor W. Gladman DD, et al. Among authors: antoni c. J Rheumatol. 2005 Nov;32(11):2262-9. J Rheumatol. 2005. PMID: 16265714
OMERACT 7 psoriatic arthritis workshop: synopsis.
Gladman DD, Strand V, Mease PJ, Antoni C, Nash P, Kavanaugh A. Gladman DD, et al. Among authors: antoni c. Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii115-6. doi: 10.1136/ard.2004.032615. Ann Rheum Dis. 2005. PMID: 15708925 Free PMC article. Review.
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).
Antoni CE, Kavanaugh A, van der Heijde D, Beutler A, Keenan G, Zhou B, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, Furst DE, Molitor J, Keystone E, Gladman DD, Manger B, Wassenberg S, Weier R, Wallace DJ, Weisman MH, Kalden JR, Smolen JS. Antoni CE, et al. J Rheumatol. 2008 May;35(5):869-76. Epub 2008 Mar 15. J Rheumatol. 2008. PMID: 18381786 Clinical Trial.
Psoriatic arthritis assessment tools in clinical trials.
Mease PJ, Antoni CE, Gladman DD, Taylor WJ. Mease PJ, et al. Among authors: antoni ce. Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii49-54. doi: 10.1136/ard.2004.034165. Ann Rheum Dis. 2005. PMID: 15708937 Free PMC article. Review.
Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors.
Fransen J, Antoni C, Mease PJ, Uter W, Kavanaugh A, Kalden JR, Van Riel PL. Fransen J, et al. Among authors: antoni c. Ann Rheum Dis. 2006 Oct;65(10):1373-8. doi: 10.1136/ard.2006.051706. Epub 2006 Apr 27. Ann Rheum Dis. 2006. PMID: 16644783 Free PMC article.
Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial.
Kavanaugh A, Krueger GG, Beutler A, Guzzo C, Zhou B, Dooley LT, Mease PJ, Gladman DD, de Vlam K, Geusens PP, Birbara C, Halter DG, Antoni C; IMPACT 2 Study Group. Kavanaugh A, et al. Among authors: antoni c. Ann Rheum Dis. 2007 Apr;66(4):498-505. doi: 10.1136/ard.2006.058339. Epub 2006 Nov 17. Ann Rheum Dis. 2007. PMID: 17114188 Free PMC article. Clinical Trial.
135 results